Pravastatin Does Not Improve Survival in Small-Cell Lung Cancer
Median overall survival of 10.6 versus 10.7 months for pravastatin versus placebo added to chemo
Cognitive Outcomes in Children No Better With Levothyroxine Tx
Subclinical hypothyroidism, hypothyroxinemia tx in pregnancy not linked to improved outcomes
Past Prescribing Behavior Predicts Choice of Insomnia Rx
Historical preference highly predictive of future prescribing behavior
Overall, 8.8 Percent of U.S. Population Uninsured in 2016
In first nine months of 2016, 12.3 percent of adults aged 18 to 64 and 5 percent of children uninsured
Wide Variation Found for Amount of Melatonin in Supplements
Almost three-quarters of supplements tested were misleadingly labeled
Reduced Health Care Use for Exenatide Regimens in T2DM
Reduced costs for patients with exenatide-based regimens prescribed once weekly or twice daily
February 2017 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for February 2017. This roundup includes the latest...
Subdural Hematomas Rising Alongside Antithrombotic Use
Highest odds of subdural hematoma for combined use of vitamin K antagonist and antiplatelet drug
Exposure to Neuraminidase Inhibitors in Utero Not Harmful
No increased risks of adverse neonatal outcomes or congenital malformations with in utero exposure
Complication Rates Often Higher in Youth With T2DM Versus T1DM
However, no longer an excess of complications for type 2 diabetes after controlling for obesity
